Intra-arterial cytotoxic therapy and x-ray therapy for cancer of the head and neck.
D008949:Adenoma, Pleomorphic / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D005153:Facial Neoplasms / Q000628:therapy; D005354:Fibrosarcoma / Q000628:therapy; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D008048:Lip Neoplasms / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D008466:Mechlorethamine / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use*; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D010157:Palatal Neoplasms / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000628:therapy; D010610:Pharyngeal Neoplasms / Q000628:therapy; D014062:Tongue Neoplasms / Q000628:therapy
D008466:Mechlorethamine; D008727:Methotrexate